Specialty Business Services
Compare Stocks
5 / 10Stock Comparison
SMX vs DOW vs EMN vs AVNT vs LYB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
SMX vs DOW vs EMN vs AVNT vs LYB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Business Services | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $497.00 | $26.86B | $8.43B | $3.35B | $23.04B |
| Revenue (TTM) | $0.00 | $39.33B | $8.64B | $3.28B | $22.48B |
| Net Income (TTM) | $-4M | $-2.76B | $399M | $158M | $-774M |
| Gross Margin | — | 6.2% | 19.8% | 31.7% | -19.3% |
| Operating Margin | — | -2.3% | 9.4% | 9.3% | -0.9% |
| Forward P/E | — | 12.6x | 12.5x | 12.0x | 9.9x |
| Total Debt | $6M | $19.60B | $5.08B | $1.92B | $15.96B |
| Cash & Equiv. | $2M | $3.82B | $566M | $511M | $3.45B |
SMX vs DOW vs EMN vs AVNT vs LYB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| SMX (Security Matte… (SMX) | 100 | 0.0 | -100.0% |
| Dow Inc. (DOW) | 100 | 65.8 | -34.2% |
| Eastman Chemical Co… (EMN) | 100 | 60.9 | -39.1% |
| Avient Corporation (AVNT) | 100 | 65.2 | -34.8% |
| LyondellBasell Indu… (LYB) | 100 | 77.5 | -22.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SMX vs DOW vs EMN vs AVNT vs LYB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, SMX doesn't own a clear edge in any measured category.
DOW ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.76, current ratio 1.97x
- +37.3% vs SMX's -100.0%
EMN is the clearest fit if your priority is efficiency.
- 2.6% ROA vs DOW's -4.6%, ROIC 6.7% vs 0.6%
AVNT carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 0.6%, EPS growth -51.6%, 3Y rev CAGR -1.4%
- 0.6% revenue growth vs LYB's -25.2%
- 4.8% margin vs SMX's -17.3%
- 2.9% yield, 14-year raise streak, vs LYB's 7.7%, (1 stock pays no dividend)
LYB is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 2 yrs, beta 0.38, yield 7.7%
- 48.6% 10Y total return vs SMX's 12.0%
- Beta 0.38, yield 7.7%, current ratio 1.77x
- Lower P/E (9.9x vs 12.5x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.6% revenue growth vs LYB's -25.2% | |
| Value | Lower P/E (9.9x vs 12.5x) | |
| Quality / Margins | 4.8% margin vs SMX's -17.3% | |
| Stability / Safety | Beta 0.38 vs SMX's 4.47 | |
| Dividends | 2.9% yield, 14-year raise streak, vs LYB's 7.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +37.3% vs SMX's -100.0% | |
| Efficiency (ROA) | 2.6% ROA vs DOW's -4.6%, ROIC 6.7% vs 0.6% |
SMX vs DOW vs EMN vs AVNT vs LYB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SMX vs DOW vs EMN vs AVNT vs LYB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVNT leads in 1 of 6 categories
LYB leads 1 • EMN leads 1 • SMX leads 0 • DOW leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DOW and SMX operate at a comparable scale, with $39.3B and $0 in trailing revenue. AVNT is the more profitable business, keeping 4.8% of every revenue dollar as net income compared to DOW's -7.0%. On growth, AVNT holds the edge at +2.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $39.3B | $8.6B | $3.3B | $22.5B |
| EBITDAEarnings before interest/tax | -$4M | $1.3B | $1.2B | $445M | $865M |
| Net IncomeAfter-tax profit | -$4M | -$2.8B | $399M | $158M | -$774M |
| Free Cash FlowCash after capex | -$1M | -$2.0B | $498M | $205M | $3.1B |
| Gross MarginGross profit ÷ Revenue | — | +6.2% | +19.8% | +31.7% | -19.3% |
| Operating MarginEBIT ÷ Revenue | — | -2.3% | +9.4% | +9.3% | -0.9% |
| Net MarginNet income ÷ Revenue | — | -7.0% | +4.6% | +4.8% | -3.4% |
| FCF MarginFCF ÷ Revenue | — | -5.1% | +5.8% | +6.3% | +13.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | -6.1% | -4.9% | +2.5% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -647.6% | -68.2% | -40.8% | +3.8% | -100.0% |
Valuation Metrics
LYB leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 56% valuation discount to AVNT's 41.0x P/E. On an enterprise value basis, EMN's 9.0x EV/EBITDA is more attractive than LYB's 33.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $497 | $26.9B | $8.4B | $3.3B | $23.0B |
| Enterprise ValueMkt cap + debt − cash | $4M | $42.6B | $12.9B | $4.8B | $35.5B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | -10.11x | 17.97x | 41.01x | -30.43x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.62x | 12.50x | 11.95x | 9.92x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 5.59x | — | — |
| EV / EBITDAEnterprise value multiple | — | 13.78x | 8.96x | 12.22x | 33.44x |
| Price / SalesMarket cap ÷ Revenue | — | 0.67x | 0.96x | 1.03x | 0.76x |
| Price / BookPrice ÷ Book value/share | 0.00x | 1.52x | 1.41x | 1.40x | 2.26x |
| Price / FCFMarket cap ÷ FCF | — | — | 19.87x | 17.16x | 59.99x |
Profitability & Efficiency
EMN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
EMN delivers a 6.7% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-15 for DOW. SMX carries lower financial leverage with a 0.27x debt-to-equity ratio, signaling a more conservative balance sheet compared to LYB's 1.56x. On the Piotroski fundamental quality scale (0–9), EMN scores 5/9 vs LYB's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.0% | -15.4% | +6.7% | +6.6% | -7.2% |
| ROA (TTM)Return on assets | -2.8% | -4.6% | +2.6% | +2.6% | -3.0% |
| ROICReturn on invested capital | -40.5% | +0.6% | +6.7% | +3.9% | -1.1% |
| ROCEReturn on capital employed | -60.1% | +0.5% | +7.5% | +4.0% | -1.1% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.27x | 1.12x | 0.84x | 0.81x | 1.56x |
| Net DebtTotal debt minus cash | $4M | $15.8B | $4.5B | $1.4B | $12.5B |
| Cash & Equiv.Liquid assets | $2M | $3.8B | $566M | $511M | $3.4B |
| Total DebtShort + long-term debt | $6M | $19.6B | $5.1B | $1.9B | $16.0B |
| Interest CoverageEBIT ÷ Interest expense | -1.24x | -1.51x | 2.22x | 3.61x | -1.42x |
Total Returns (Dividends Reinvested)
Evenly matched — EMN and LYB each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LYB five years ago would be worth $8,867 today (with dividends reinvested), compared to $0 for SMX. Over the past 12 months, DOW leads with a +37.3% total return vs SMX's -100.0%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs SMX's -99.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.8% | +55.2% | +15.8% | +16.0% | +62.6% |
| 1-Year ReturnPast 12 months | -100.0% | +37.3% | +2.3% | +4.1% | +37.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | -17.5% | +3.4% | +2.3% | -5.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -27.2% | -28.4% | -22.7% | -11.3% |
| 10-Year ReturnCumulative with dividends | +1200.0% | +12.2% | +35.4% | +27.8% | +48.6% |
| CAGR (3Y)Annualised 3-year return | -99.0% | -6.2% | +1.1% | +0.8% | -1.9% |
Risk & Volatility
Evenly matched — EMN and LYB each lead in 1 of 2 comparable metrics.
Risk & Volatility
LYB is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than SMX's 4.47 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EMN currently trades 87.5% from its 52-week high vs SMX's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.47x | 0.76x | 1.36x | 1.19x | 0.38x |
| 52-Week HighHighest price in past year | $20528.69 | $42.74 | $84.18 | $44.85 | $83.94 |
| 52-Week LowLowest price in past year | $1.02 | $20.40 | $56.11 | $27.48 | $41.58 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +87.3% | +87.5% | +81.4% | +85.2% |
| RSI (14)Momentum oscillator 0–100 | 30.1 | 48.9 | 56.9 | 55.2 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 2.8M | 14.4M | 1.5M | 620K | 8.1M |
Analyst Outlook
Evenly matched — AVNT and LYB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DOW as "Hold", EMN as "Buy", AVNT as "Buy", LYB as "Hold". Consensus price targets imply 32.6% upside for AVNT (target: $48) vs 2.9% for LYB (target: $74). For income investors, LYB offers the higher dividend yield at 7.66% vs AVNT's 2.95%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $39.55 | $77.29 | $48.40 | $73.60 |
| # AnalystsCovering analysts | — | 35 | 35 | 20 | 39 |
| Dividend YieldAnnual dividend ÷ price | — | +5.6% | +4.5% | +2.9% | +7.7% |
| Dividend StreakConsecutive years of raises | — | 0 | 12 | 14 | 2 |
| Dividend / ShareAnnual DPS | — | $2.09 | $3.30 | $1.08 | $5.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.2% | +0.1% | +0.9% |
AVNT leads in 1 of 6 categories (Income & Cash Flow). LYB leads in 1 (Valuation Metrics). 3 tied.
SMX vs DOW vs EMN vs AVNT vs LYB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SMX or DOW or EMN or AVNT or LYB a better buy right now?
For growth investors, Avient Corporation (AVNT) is the stronger pick with 0.
6% revenue growth year-over-year, versus -25. 2% for LyondellBasell Industries N. V. (LYB). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Eastman Chemical Company (EMN) a "Buy" — based on 35 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SMX or DOW or EMN or AVNT or LYB?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Avient Corporation at 41. 0x. On forward P/E, LyondellBasell Industries N. V. is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SMX or DOW or EMN or AVNT or LYB?
Over the past 5 years, LyondellBasell Industries N.
V. (LYB) delivered a total return of -11. 3%, compared to -100. 0% for SMX (Security Matters) Public Limited Company (SMX). Over 10 years, the gap is even starker: SMX returned +1200% versus DOW's +12. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SMX or DOW or EMN or AVNT or LYB?
By beta (market sensitivity over 5 years), LyondellBasell Industries N.
V. (LYB) is the lower-risk stock at 0. 38β versus SMX (Security Matters) Public Limited Company's 4. 47β — meaning SMX is approximately 1073% more volatile than LYB relative to the S&P 500. On balance sheet safety, SMX (Security Matters) Public Limited Company (SMX) carries a lower debt/equity ratio of 27% versus 156% for LyondellBasell Industries N. V. — giving it more financial flexibility in a downturn.
05Which is growing faster — SMX or DOW or EMN or AVNT or LYB?
By revenue growth (latest reported year), Avient Corporation (AVNT) is pulling ahead at 0.
6% versus -25. 2% for LyondellBasell Industries N. V. (LYB). On earnings-per-share growth, the picture is similar: SMX (Security Matters) Public Limited Company grew EPS 94. 3% year-over-year, compared to -335. 0% for Dow Inc.. Over a 3-year CAGR, AVNT leads at -1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SMX or DOW or EMN or AVNT or LYB?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -6. 6% for Dow Inc. — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 1% for LYB. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SMX or DOW or EMN or AVNT or LYB more undervalued right now?
On forward earnings alone, LyondellBasell Industries N.
V. (LYB) trades at 9. 9x forward P/E versus 12. 6x for Dow Inc. — 2. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AVNT: 32. 6% to $48. 40.
08Which pays a better dividend — SMX or DOW or EMN or AVNT or LYB?
In this comparison, LYB (7.
7% yield), DOW (5. 6% yield), EMN (4. 5% yield), AVNT (2. 9% yield) pay a dividend. SMX does not pay a meaningful dividend and should not be held primarily for income.
09Is SMX or DOW or EMN or AVNT or LYB better for a retirement portfolio?
For long-horizon retirement investors, LyondellBasell Industries N.
V. (LYB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 7. 7% yield). SMX (Security Matters) Public Limited Company (SMX) carries a higher beta of 4. 47 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LYB: +48. 6%, SMX: +1200%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SMX and DOW and EMN and AVNT and LYB?
These companies operate in different sectors (SMX (Industrials) and DOW (Basic Materials) and EMN (Basic Materials) and AVNT (Basic Materials) and LYB (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SMX is a small-cap quality compounder stock; DOW is a mid-cap income-oriented stock; EMN is a small-cap deep-value stock; AVNT is a small-cap quality compounder stock; LYB is a mid-cap income-oriented stock. DOW, EMN, AVNT, LYB pay a dividend while SMX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.